CHARLOTTE FIGI WAS five when she made history in 2011 as the youngest patient in Colorado to receive cannabidiol treatment. Doctors prescribed the substance, known as CBD, to soothe her violent seizures, and within two years she was walking, talking, and eating on her own. Encouraged by Figi’s case, in 2018 the Food and Drug Administration approved the first US medication made with CBD, a compound that’s less psychoactive and habit-forming than others in cannabis.
Supplement makers hawk it as a cure-all in everything from pain-relief patches to pet treats. CBD does indeed show promise in treating childhood epilepsy, schizophrenia, sleep deprivation, and anxiety disorders. But for now, that’s where any hard data on its usefulness ends. “There are many unanswered questions about the science, safety, quality, and physiological effects,”…